EEG alpha sensitization in individualized homeopathic treatment of fibromyalgia

International Journal of Neuroscience

Volumn 114, Issue 9, 2004, Pages 1195-1220

  Bell, Iris R ^a,d   Lewis II, Daniel A ^b   Lewis, Sabrina E ^b   Schwartz, Gary E ^c   Brooks, Audrey J ^c   Scott, Anne ^c   Baldwin, Carol M ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b SAYBROOK UNIVERSITY   (United States)

^c University of Arizona   (United States)

^d Program in Integrative Medicine   (United States)

Author keywords

EEG alpha; Fibromyalgia; Homeopathy; Olfactory administration; Oscillation; Time dependent sensitization

Indexed keywords

ADULT; ALPHA RHYTHM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FIBROMYALGIA; HOMEOPATHY; HUMAN; MALE; SENSITIZATION; SNIFFING;

ADULT; ALPHA RHYTHM; BIOLOGICAL MARKERS; BRAIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; HOMEOPATHY; HUMANS; MALE; MIDDLE AGED; SMELL;

EID: 4544359928     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207450490475724     Document Type: Article

References (82)

1. Antelman, S. M. (1994). Time-dependent sensitization in animals: A possible model of multiple chemical sensitivity in humans. Toxicology & Industrial Health, 10(4-5), 335-342.
2. Antelman, S. M., & Caggiula, A. R. (1996). Oscillation follows drug sensitization: Implications. Critical Reviews in Neurobiology, 10(1), 10 1-117.
3. Antelman, S. M., Caggiula, A. R., Gershon, S., Edwards, D. J., Austin, M. C., Kiss, S., & Kocan, D. (1997). Stressor-induced oscillation. A possible model of the bidirectional symptoms in PTSD. Annals of the New York Academy of Sciences, 821, 296-304.
4. Antelman, S. M., Eichler, A. J., Black, C. A., & Kocan, D. (1980). Interchangeability of stress and amphetamine in sensitization. Science, 207(4428), 329-331.
5. Antelman, S. M., Knopf, S., Kocan, D., Edwards, D. J., Ritchie, J. C., & Nemeroff, C. B. (1988). One stressful event blocks multiple actions of diazepam for up to at least a month. Brain Research, 445(2), 380-385.
6. Antelman, S. M., Kocan, D., Knopf, S., Edwards, D. J., & Caggiula, A. R. (1992). One brief exposure to a psychological Stressor induces long-lasting, time-dependent sensitization of both the cataleptic and neurochemical responses to haloperidol. Life Sciences, 51(4), 261-266.
7. Bardo, M. T., Bowling, S. L., Rowlett, J. K., Manderscheid, P., Buxton, S. T., & Dwoskin, L. P. (1995). Environmental enrichment attenuates locomotor sensitization, but not in vitro dopamine release, induced by amphetamine. Pharmacology, Biochemistry & Behavior, 51(2-3), 397-405.
8. Bastide, M., & Lagache, A. (1997). A communication process: A new paradigm applied to high-dilution effects on the living body. Alternative Therapies in Health & Medicine, 3(4), 35-39.
9. Bath, P. A. (1999). Self-rated health as a risk factor for prescribed drug use and future health and social service use in older people. Journal of Gerontology, Series A, 54(11), M565-M570.
10. Bell, I. R., Baldwin, C. M., Fernandez, M., & Schwartz, G. E. (1999). Neural sensitization model for multiple chemical sensitivity: Overview of theory and empirical evidence. Toxicology & Industrial Health, 15(3-4), 295-304.
11. Bell, I. R., Baldwin, C. M., & Schwartz, G. E. (2001). Sensitization studies in chemically intolerant individuals: Implications for individual difference research. Annals of the New York Academy of Sciences, 933, 38-47.
12. Bell, I. R., Baldwin, C. M., & Schwartz, G. E. (2002). Translating a nonlinear systems theory model for homeopathy into empirical tests. Alternative Therapies in Health & Medicine, 8(3), 58-66.
13. Bell, I. R., Baldwin, C. M., Stoltz, E., Walsh, B. T., & Schwartz, G. E. (2001). EEG beta 1 oscillation and sucrose sensitization in fibromyalgia with chemical intolerance. International Journal of Neuroscience, 108(1-2), 31-42.
14. Bell, I. R., Baldwin, C. M., & Schwartz, G. E. (1998). Illness from low levels of environmental chemicals: Relevance to chronic fatigue syndrome and fibromyalgia. American Journal of Medicine, 105 Supplement(3A), 74S-82S.
15. Bell, I. R., Baldwin, C. M., Stoltz, E., Walsh, B. T., & Schwartz, G. E. R. (2001). Concomitant environmental chemical intolerance modifies the neurobehavioral presentation of women with fibromyalgia. Journal of Chronic Fatigue Syndrome, 9(1-2), 3-19.
16. Bell, I. R., Koithan, M., Gorman, M. M., & Baldwin, C. M. (2003). Homeopathic practitioner views of changes in patients undergoing constitutional treatment for chronic disease. Journal of Alternative & Complementary Medicine, 9(1), 39-50.
17. Bell, I. R., Lewis, D. A., Brooks, A. J., Lewis, S., & Schwartz, G. E. (2003). Gas discharge visualization evaluation of ultramolecular doses of homeopathic medicines under blinded, controlled conditions. Journal of Alternative & Complementary Medicine, 9(1), 25-38.
18. Bell, I. R., Lewis, D. A., Brooks, A. J., Schwartz, G. E., Lewis, S. E., Caspi, O., Cunningham, V., & Baldwin, C. Cm. (2004b). Individual differences in response to randomly-assigned active individualized homeopathic and placebo treatment in fibromyalgia: Implications of a double-blind optional crossover design. Journal of Alternative & Complementary Medicine, 10, 269-283.
19. Bell, I. R., Lewis, D. A., Schwartz, G. E., Lewis, S. E., Caspi, O., Scott, A., Brooks, A. J., & Baldwin, C. M. (2004c). Electroencephalographic cordance patterns distinguish exceptional clinical responders with fibromyalgia to individualized homeopathic medicines. Journal of Alternative & Complementary Medicine, 10, 285-299.
20. Bell, I. R., Lewis, D. A. Brooks, A. J., Schwartz, G. E., Lewis, S. E., Walsh, B. T., & Baldwin, C. M. (2004a). Improved clinical status in fibromyalgia patients treated with individualized homeopathic remedies versus placebo. Rheumatology, 43, 577-582.
21. Bell, I. R., Schwartz, G. E., Hardin, E. E., Baldwin, C. M., & Kline, J. P. (1998). Differential resting qEEG alpha patterns in women with environmental chemical intolerance, depressives, and normals. Biological Psychiatry, 43(5), 376-388.
22. Bell, I. R., Warg-Damiani, L., Baldwin, C. M., Walsh, M. E., & Schwartz, G. E. (1998). Self-reported chemical sensitivity and wartime chemical exposures in Gulf War veterans with and without decreased global health ratings. Military Medicine, 163(11), 725-732.
23. Bellavite, P., & Signorini, A. (2002). The emerging science of homeopathy complexity, biodynamics, and nanopharmacology (2nd ed.). Berkeley: North Atlantic Books.
24. Bernstein, D., Fink, L., & Handelsman, L. (1994). Initial reliability and validity of a new retrospective measure of child abuse and neglect. American Journal of Psychiatry, 151, 1132-1136.
25. Bjijou, Y., De Deurwaerdere, P., Spampinato, U., Stinus, L., & Cador, M. (2002). D-amphetamine-induced behavioral sensitization: Effect of lesioning dopaminergic terminals in the medial prefrontal cortex, the amygdala and the entorhinal cortex. Neuroscience, 109(3), 499-516.
26. Calabrese, E. J., & Baldwin, L. A. (2001). Hormesis: A generalizable and unifying hypothesis. Critical Reviews in Toxicology, 31, 353-424.
27. Cook, I. A., Leuchter, A. F., Morgan, M., Witte, E., Stubbeman, W. F., Abrams, M., Rosenberg, S., & Uijtdehaage, S. H. (2002). Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology, 27(1), 120-131.
28. Crombag, H. S., Badiani, A., Chan, J., Dell'Orco, J., Dineen, S. P., & Robinson, T. E. (2001). The ability of environmental context to facilitate psychomotor sensitization to amphetamine can be dissociated from its effect on acute drug responsiveness and on conditioned responding. Neuropsychopharmacology, 24(6), 680-690.
29. Davidson, J. (1994). Psychiatry and homeopathy. Basis for a dialogue. British Homoeopathic Journal. 83, 78-83.
30. De Schepper, L. (1999). LM potencies: One of the hidden treasures of the sixth edition of the Organon. British Homoeopathic Journal, 88(3), 128-134.
31. Elia, V., & Niccoli, M. (1999). Thermodynamics of extremely diluted aqueous solutions. Annals of the New York Academy of Sciences, 879, 241-248.
32. Ernst, E., & Hahn, E. G. (Eds.). (1998). Homeopathy. A critical appraisal. Oxford: Butterworth-Heinemann.
33. Ernst, E., & Resch, K. L. (1995). The "optional cross-over design" for randomized controlled trials. Fundamental Clinical Pharmacology, 9, 508-511.
34. Ferger, B., Kuschinsky, K. (1996). Effects of cocaine on the EEG power spectrum of rats are significantly altered after its repeated administration: Do they reflect sensitization phenomena? Naunyn-Schmeideberg's Archives of Pharmacology, 353, 545-551.
35. Fernandez, M., Bell, I. R., & Schwartz, G. E. (1999). EEG sensitization during chemical exposure in women with and without chemical sensitivity of unknown etiology. Toxicology & Industrial Health, 15(3-4), 305-312.
36. Fisher, P., Greenwood, A., Huskisson, E.G., Turner, P., & Belon, P. (1989). Effect of homeopathic treatment on fibrositis (primary fibromyalgia). British Medical Journal. 299, 365-366.
37. Friedberg, F., & Jason, L. A. (2001). Chronic fatigue syndrome and fibromyalgia: Clinical assessment and treatment. Journal of Clinical Psychology, 57(4), 433-455.
38. Granot, M., Buskila, D., Granovsky, Y., Sprecher, E., Neumann, L., & Yarnitsky, D. (2001). Simultaneous recording of late and ultra-late pain evoked potentials in fibromyalgia. Clinical Neurophysiology, 112(10), 1881-1887.
39. Harada, H., Shiraishi, K., Kato, T., & Soda, T. (1996). Coherence analysis of EEG changes during odour stimulation in humans. Journal of Laryngology & Otology, 110(1), 652-656.
40. Hoshaw, B. A., & Lewis, M. J. (2001). Behavioral sensitization to ethanol in rats: Evidence from the Sprague-Dawley strain. Pharmacology, Biochemistry & Behavior, 68(4), 685-690.
41. Hyland, M. E., & Lewith, G. T. (2002). Oscillatory effects in a homeopathic clinical trial: An explanation using complexity theory, and implications for clinical practice. Homeopathy, 91(3), 145-149.
42. Idler, E., & Benyamini, Y. (1997). Self-rated health and mortality: A review of twenty-seven community studies. Journal of Health and Social Behavior, 38, 21-36.
43. Idler, E. L., & Kasi, S. (1991). Health perceptions and survival: Do global evaluations of health status really predict mortality? Journal of Gerontology, 46(2), S55-S65.
44. Jonas, W. B., Kaptchuk, T. J., & Linde, K. (2003). A critical overview of homeopathy. Annals of Internal Medicine, 138(5), 393-399.
45. Langman, M. J. S. (1997). Homeopathy trials: Reason for good ones but are they warranted? Lancet, 350, 825.
46. Leuchter, A. F., Cook, I. A., Witte, E. A., Morgan, M., & Abrams, M. (2002). Changes in brain function of depressed subjects during treatment with placebo. American Journal of Psychiatry. 159(1), 122-129.
47. Linde, K., Clausius, N., Ramirez, G., Melchart, D., Eitel, F., Hedges, L. V., & Jonas, W. B. (1997). Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet, 350, 834-843.
48. Linde, K., Jonas, W. B., Melchart, D., Worku, F., Wagner, H., & Eitel, F. (1994). Critical review and meta-analysis of serial agitated dilutions in experimental toxicology. Human Experimental Toxicology, 13, 481-492.
49. Locatelli, M., Bellodi, L., Grassi, B., & Scarone, S. (1996). EEG power modifications in obsessive-compulsive disorder during olfactory stimulation. Biological Psychiatry, 39(5), 326-331.
50. Locatelli, M., Bellodi, L., Perna, G., & Scarone, S. (1993). EEG power modifications in panic disorder during a temporolimbic activation task: Relationships with temporal lobe clinical symptomatology. Journal of Neuropsychiatry & Clinical Neurosciences, 5(4), 409-414.
51. Masago, R., Matsuda, T., Kikuchi, Y., Miyazaki, Y., Iwanaga, K., Harada, H., & Katsuura, T. (2000). Effects of inhalation of essential oils on EEG activity and sensory evaluation. Journal of Physiological Anthropology & Applied Human Science, 79(1), 35-42.
52. McNair, D. M., Lorr, M., & Droppleman, L. F. (1981). Manual for the Profile of Mood States Scale (POMS). San Diego, CA: Educational and Industrial Testing Service.
53. Menee, V. H., Chipperfield, J. G., & Perry, R. P. (1999). Self-perceptions of health: A prospective analysis of mortality, control, and health. Journals of Gerontology Series B-Psychological Sciences & Social Sciences, 54(2), 85-93.
54. Merrell, W. C., & Shalts, E. (2002). Homeopathy. Medical Clinics of North America, 86(1), 47-62.
55. Newlin, D. B., & Thomson, J. B. (1991). Chronic tolerance and sensitization to alcohol in sons of alcoholics. Alcoholism: Clinical & Experimental Research, 15(3), 399-405.
56. Ostrander, M. M., Hartman, J., Badiani, A., Robinson, T. E., & Gnegy, M. E. (1998). The effect of environment on the changes in calmodulin in rat brain produced by repeated amphetamine treatment. Brain Research, 797(2), 339-341.
57. Pioro-Boisset, M., Esdaile, J. M., & Fitzcharles, M. A. (1996). Alternative medicine use in fibromyalgia syndrome, [comment]. Arthritis Care & Research, 9(1), 13-17.
58. Pontieri, F. E., Monnazzi, P., Scontrini, A., Buttarelli, F. R., & Patacchioli, F. R. (2001). Behavioral sensitization to heroin by cannabinoid pretreatment in the rat. European Journal of Pharmacology, 421(3), R1-R3.
59. Rey, L. (2003). Thermoluminescence of ultra-high dilutions of lithium chloride and sodium chloride. Physics A, 323, 67-74.
60. Rowe, T. (1998). Homeopathic methodology. Repertory, case taking, and case analysis. Berkeley: North Atlantic Books.
61. Ruiz-Vega, G., Perez-Ordaz, L., Leon-Hueramo, O., Cruz-Vazquez, E., & Sanchez-Diaz, N. (2002). Comparative effect of Coffea cruda potencies on rats. Homeopathy: the Journal of the Faculty of Homeopathy, 91(2), 80-84.
62. Schwanz, G. E., Bell, I. R., Dikman, Z. V., Fernandez, M., Kline, J. P., Peterson, J. M., & Wright, K. P. (1994). EEG responses to low-level chemicals in normals and cacosmics. Toxicology & Industrial Health, 10(4-5), 633-643.
63. Slotkoff, A. T., Radulovic, D. A., & Clauw, D. J. (1997). The relationship between fibromyalgia and the multiple chemical sensitivity syndrome. Scandinavian Journal of Rheumatology, 26(5), 364-367.
64. Sorg, B., Bailie, T., Tschirgi, M., Li, N., & Wu, W. (2001a). Exposure to repeated low-level formaldehyde in rats increases basal corticosterone levels and enhances the corticosterone response to subsequent formaldehyde. Brain Research, 898(2), 314-320.
65. Sorg, B. A., Bailie, T. M., Tschirgi, M. L., Li, N., & Wu, W. R. (2001b). Exposure to repeated low-level formaldehyde in rats increases basal corticosterone levels and enhances the corticosterone response to subsequent formaldehyde. Brain Research, 898(2), 314-320.
66. Sorg, B. A., & Prasad, B. M. (1997). Potential role of stress and sensitization in the development and expression of multiple chemical sensitivity. Environmental Health Perspectives, 105(Suppl 2), 467-471.
67. Sorg, B. A., Tschirgi, M. L., Swindell, S., Chen, L., & Fang, J. (2001). Repeated formaldehyde effects in an animal model for multiple chemical sensitivity. Annals of the New York Academy of Sciences, 933, 57-67.
68. Sorg, B. A., Willis, J. R., See, R. E., Hopkins, B., & Westberg, H. H. (1998). Repeated low-level formaldehyde exposure produces cross-sensitization to cocaine: Possible relevance to chemical sensitivity in humans. Neuropsychopharmacology, 18(5), 385-394.
69. Stahl, D., Ferger, B., & Kuschinsky, K. (1997). Sensitization to d-amphetamine after its repeated administration: Evidence in EEG and behaviour. Naunyn-Schmiedebergs Archives of Pharmacology, 356(3), 335-340.
70. Staud, R., Vierck, C. J., Cannon, R. L., Mauderli, A. P., & Price, D. D. (2001). Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain, 91(1-2), 165-175.
71. Sukul, N. C., Bala, S. K., & Bhattacharyya, B. (1986). Prolonged cataleptogenic effects of potentized homoeopathic drugs. Psychopharmacology, 89, 338-339.
72. Szarek, M. J., Bell, I. R., & Schwanz, G. E. (1997). Validation of a brief screening measure of environmental chemical sensitivity: The chemical odor intolerance index. Journal of Environmental Psychology, 17(4), 345-351.
73. Tabachnick, B. G., & Fidell, L. S. (2001). Using multivariate statistics (4th ed.). Boston: Allyn and Bacon.
74. Ursin, H., & Eriksen, H. R. (2001). Sensitization, subjective health complaints, and sustained arousal. Annals of the New York Academy of Sciences, 933, 119-129.
75. Vandenbroucke, J. P. (1997). Homeopathy trials: Going nowhere. Lancet, 350, 824.
76. Vandenbroucke, J. P., & de Craen, A. J. (2001). Alternative medicine: A "mirror image" for scientific reasoning in conventional medicine. Annals of Internal Medicine, 135(1), 507-513.
77. Vanderwolf, C. H., & Zibrowski, E. M. (2001). Pyriform cortex beta-waves: Odor-specific sensitization following repeated olfactory stimulation. Brain Research, 892(2), 301-308.
78. Vickers, A. J. (1999). Independent replication of pre-clinical research in homeopathy: A systematic review. Forschende Komplementarmedizin, 6(6), 311-320.
79. Vickers, A. J. (2000). Clinical trials of homeopathy and placebo: Analysis of a scientific debate. Journal of Alternative & Complementary Medicine, 6(1), 49-56.
80. Vithoulkas, G. (1980). The science of homeopathy. NY: Grove Weidenfeld.
81. Walker, E. A., Keegan, D., Gardner, G., Sullivan, M., Bernstein, D., & Katon, W. J. (1997). Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosomatic Medicine, 59(6), 572-577.
82. Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C, Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., Fam, A. G.; Farber, S. J., Flechter, J. J., Franklin, C. M., Garter, R. A., Hanaty, D., Lessard, J., Lichtbroun, A. A., Niasi, A. T., McCain, G. A., Reynolds, W. J., Romano, T. J., Russell, I. J., & Sheon, R. P. (1990). The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the multicenter criteria committee. Arthritis Rheumatism, 33, 160-172.